NT157

NT157

Catalog Number:
L002372645APE
Mfr. No.:
APE-B7808
Price:
$231
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          IC50: 0.3 to 0.8 μM
          NT157 is an IRS-1/2 inhibitor.
          Insulin receptor substrates 1 and 2 (IRS1/2) mediate antiapoptotic and mitogenic signaling from insulin receptor (IR), insulin-like growth factor 1 receptor (IGF-IR), and other oncoproteins. IRS1 plays a critical role in cancer cell proliferation, and its expression is increased in many human malignancies.
          In vitro: NT157 treatment was fonund to be able to lead to dose-dependent suppression of IRS protein expression, inhibition of IGF1R activation, inhibition of IGF1-induced AKT activation, but increased ERK activation in NT157-treated cells. These effects were associated with decreased proliferation, increased apoptosis of LNCaP cells and increased G2-M arrest in PC3 cells. Moreover, NT157 could significantly affect the cell migratory ability, as demonstrated by a wound-healing assay. In addition, the NT157 treatment was able to induce cell cycle arrest and inhibit IGF system signaling [1].
          In vivo: In previous animal study, NT157 was found to suppress androgen-responsive growth, delay CRPC progression of LNCaP xenografts, and suppress PC3 tumor growth alone or in combination with docetaxel. This study reported the first preclinical proof-of-principle data that NT157 suppressed IRS1/2 expression, delayed CRPC progression, and suppressed growth of CRPC tumors in vivo [1].
          Clinical trial: Up to now, NT157 is still in the preclinical development stage.

      • Properties
        • Alternative Name
          (E)-3-(3-bromo-4,5-dihydroxyphenyl)-N-(3,4,5-trihydroxybenzyl)prop-2-enethioamide
          CAS Number
          1384426-12-3
          Molecular Formula
          C16H14BrNO5S
          Molecular Weight
          412.26
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          insoluble in H2O; ≥21.5 mg/mL in EtOH; ≥50 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Janse van Rensburg HJ, Lai D, et al. "TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1." Cell Signal. 2018 Aug 20;52:12-22. PMID:30138697

    We Also Recommend

    RK-33

    $335

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.